PlexusDx exclusively partners with licensed 503A compounding pharmacies to provide customized semaglutide, tirzepatide, and GLP-Squared dual compounds
The only contraindication to statin therapy is acute, active liver disease
Noting the no or very limited treatment options for congenital hyperinsulinism, Zealand Chief Medical Officer David Kendall said the company is committed to working with the FDA and our third-party manufacturing partner to bring dasiglucagon to patients living with this devastating disease in the months ahead. September 30 Product: Fresenius Kabi and Formycons Otulfi Indication : Crohns disease, ulcerative colitis, plaque psoriasis and active psoriatic arthritis Theres a new Stelara biosimilar on the block after the FDA greenlit Otulfi, from partners Fresenius Kabi and Formycon, for the treatment of Crohns disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritisall conditions for which the reference product is also approved
The 18-arm study will measure 24-hour pharmacokinetics and tolerability, compare pills versus capsules, and test alternative enhancers such as sodium caprate
